FDA Launches Pilot Program To Fast-Track Review Of Generic Drugs Made In U.S.
The Food and Drug Administration announced Friday it is launching a new pilot program aimed at speeding up the review process for generic drugs that are both tested and manufactured entirely in the United States. The initiative is designed to…
